KCG Holdings Inc. bought a new stake in Rockwell Medical, Inc. (NASDAQ:RMTI) during the first quarter, Holdings Channel reports. The institutional investor bought 17,671 shares of the company’s stock, valued at approximately $111,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its position in Rockwell Medical by 9.7% in the first quarter. Geode Capital Management LLC now owns 371,700 shares of the company’s stock valued at $2,326,000 after buying an additional 32,964 shares during the period. Vanguard Group Inc. increased its position in Rockwell Medical by 4.9% in the first quarter. Vanguard Group Inc. now owns 1,990,057 shares of the company’s stock valued at $12,458,000 after buying an additional 93,589 shares during the period. American International Group Inc. increased its position in Rockwell Medical by 7.1% in the first quarter. American International Group Inc. now owns 29,509 shares of the company’s stock valued at $185,000 after buying an additional 1,955 shares during the period. Balasa Dinverno & Foltz LLC increased its position in Rockwell Medical by 6.2% in the first quarter. Balasa Dinverno & Foltz LLC now owns 51,300 shares of the company’s stock valued at $321,000 after buying an additional 3,000 shares during the period. Finally, Geneva Advisors LLC increased its position in Rockwell Medical by 3.7% in the first quarter. Geneva Advisors LLC now owns 20,970 shares of the company’s stock valued at $131,000 after buying an additional 750 shares during the period. 20.54% of the stock is currently owned by institutional investors and hedge funds.

Rockwell Medical, Inc. (RMTI) remained flat at $6.37 on Friday. The company had a trading volume of 23,611 shares. The firm’s market cap is $329.58 million. The company has a 50-day moving average price of $7.46 and a 200 day moving average price of $6.88. Rockwell Medical, Inc. has a 12 month low of $3.55 and a 12 month high of $8.98.

Rockwell Medical (NASDAQ:RMTI) last posted its quarterly earnings data on Wednesday, August 9th. The company reported ($0.14) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.10) by $0.04. The company had revenue of $13.24 million during the quarter, compared to analyst estimates of $13.05 million. Rockwell Medical had a negative return on equity of 40.38% and a negative net margin of 39.68%. Rockwell Medical’s revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.11) earnings per share. Equities analysts expect that Rockwell Medical, Inc. will post ($0.43) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “KCG Holdings Inc. Takes Position in Rockwell Medical, Inc. (RMTI)” was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/kcg-holdings-inc-takes-position-in-rockwell-medical-inc-rmti/1475263.html.

Several research firms have recently weighed in on RMTI. Zacks Investment Research raised shares of Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, July 12th. BidaskClub downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Finally, ValuEngine downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Friday, June 2nd. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $7.50.

Rockwell Medical Company Profile

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc. (NASDAQ:RMTI).

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.